Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1/Leucovorin vs sLV5FU2 in Elderly Advanced Colorectal Cancer
NCT01193452Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Aug 2010
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of tegafur in colorectal cancer (CRC) (2 arms), sponsored by Fudan University. Primary endpoint: Response Rate at 6 weeks. Status: unknown.
02
Drugs
tegafur
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01193452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01193452.